Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
02/2012
02/08/2012EP1948242B9 Cytotoxic compounds
02/08/2012EP1409456B1 Detection of transmembrane potentials by optical methods
02/08/2012CN1934091B 治疗神经变性障碍的咪唑化合物 Treatment of neurodegenerative disorders imidazole compound
02/08/2012CN102348698A Inhibitors of beta-secretase
02/08/2012CN102348693A Processes for preparing JAK inhibitors and related intermediate compounds
02/08/2012CN102348684A Halogenalkylmethylenoxy-phenyl-substituted ketoenols
02/08/2012CN102344549A Porphyrin-pyrrolopyrrole copolymer containing carbazole, preparation method thereof and application thereof
02/08/2012CN102344452A A novel process for the synthesis of pemetrexed disodium salt
02/08/2012CN102344443A Open-loop maleimide compound utilizing click chemosynthesis and application in treating diseases thereof
02/08/2012CN101792447B 气相法乌洛托品制备装置 Fumed methenamine preparation device
02/08/2012CN101641361B 四氢咪唑并[1,5-a]吡嗪类衍生物,其制备方法及其在医药上的应用 Tetrahydroimidazo [1,5-a] pyrazine derivatives, their preparation and their applications in medicine
02/08/2012CN101137436B 碱稳定性离子液体 Alkaline stability of ionic liquids
02/07/2012US8110690 Substituted indolocarbazoles
02/07/2012US8110580 Thiophene pyrazolopyrimidine compounds
02/07/2012CA2655754C 4-amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidine derivatives, methods for their preparation and their use as antiviral agents
02/07/2012CA2524222C N.epsilon. and/or n.alpha. derivatized, metal and organic protected l-histidine for coupling to biomolecules for highly efficient labeling with [m(oh2)3(co)3]+ by fac coordination
02/07/2012CA2517129C Mono amine and diamine derivatives of cl-20
02/02/2012WO2012016095A1 Process for the preparation of the compound osi - 906
02/02/2012WO2012015677A1 6- (1-methyl-1h-pyrazol-4-yl)-3-(2-methyl-2h-indazol-5-
02/02/2012WO2012015265A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
02/02/2012WO2012014147A1 Anticancer derivatives, preparation thereof and therapeutic use thereof
02/02/2012WO2012013640A1 Process for the preparation of dimiracetam
02/02/2012WO2011123536A8 Polycyclic tetracycline compounds
02/02/2012US20120029190 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
02/02/2012US20120029044 7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof
02/02/2012US20120029021 Nitroxide Free Radical Synergized Antineoplastic Agents
02/02/2012US20120028986 2-heteroaryl-pyrrolo [3,4-c]pyrrole derivatives, and use thereof as scd inhibitors
02/02/2012US20120028984 Compound Useful As A c-MET Inhibitor
02/02/2012US20120028979 2-(piperidin-1-yl)-4-heterocyclyl-thiazole-5-carboxylic acid derivatives against bacterial infections
02/02/2012US20120028968 Novel dibenzofuranyl-oxadiazolyl-diazabicyclononane derivatives and their medical use
02/02/2012US20120028967 Novel diaza-bicyclononyl-pyrimidinyl derivatives and their medical use
02/02/2012US20120028966 Protein kinase inhibitors
02/02/2012US20120028962 Fused heterocyclic ring compound
02/02/2012US20120028958 5-alkynyl-pyrimidines
02/02/2012US20120028919 Pyrrolotriazines as alk and jak2 inhibitors
02/02/2012US20120028907 Methods for identification of tumor phenotype and treatment
02/02/2012US20120028045 Processes for the Preparation of Indiplon and Intermediates Thereof
02/02/2012US20120027733 Compositions to effect neuronal growth
02/02/2012US20120027692 Pyrrolopyrimidinedione and its therapeutic use
02/02/2012CA2806665A1 Anticancer derivatives, preparation thereof and therapeutic use thereof
02/02/2012CA2806655A1 Substituted imidazo[1,2-b]pyridazines
02/02/2012CA2805494A1 6-(1-methyl-1h-pyrazol-4-yl)-3-(2-methyl-2h-indazol-5-ylthio)-[1,2,4] triazolo [4,3-b] pyridazine as a c-met inhibitor
02/02/2012CA2800345A1 Process for the preparation of the compound osi - 9 06
02/01/2012EP2411986A1 Diketopyrrolopyrrole polymers for use in organic semiconductor devices
02/01/2012EP2411394A2 Useful pharmaceutical salts of 7-[(3r, 4r)-3-hydroxy-4-hydroxymethyl-pyrrolidin-1-ylmethyl]-3,5-dihydro-pyrrolo[3,2-d]pyrimidin-4-one
02/01/2012EP2410844A1 Inhibitors of hepatitis c virus replication
02/01/2012EP2331546B1 2-alkyl-6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-ib]-pyridazine derivatives, preparation thereof, and therapeutic application thereof
02/01/2012EP2078016B1 Heteroaryl compounds, compositions thereof, and methods of treatment therewith
02/01/2012EP1934176B1 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels
02/01/2012EP1848719B1 [1h-pyrazolo[3,4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases
02/01/2012EP1274983B1 Colorimetric artificial nose having an array of dyes and method for artificial olfaction
02/01/2012CN1742731B 治疗雌性性机能障碍的吡唑并嘧啶酮类 Treatment of female sexual dysfunction Pyrazolopyrimidine ketones
02/01/2012CN102341400A Pyrrolopyrimidines used as kinase inhibitors
02/01/2012CN102341399A Quinoxaline compounds
02/01/2012CN102341398A Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
02/01/2012CN102341397A Improved chemical synthesis of diazaindoles by chichibabin cyclization
02/01/2012CN102341396A Material for use in phosphorescent device and organic electroluminescent device using same
02/01/2012CN102336831A Anti-sildenafil specific antibody
02/01/2012CN102336759A Preparation method of planar binuclear metal phthalocyanine coordination compound
02/01/2012CN102336758A Compound and combination as HCV polymerase inhibitors
02/01/2012CN102336712A Nitrogen-containing heterocyclic ring derivatives synthesized by transition metal salt induced intermolecular cyclization and preparation method thereof
02/01/2012CN101273045B 7-[2-[4-(6-氟-3-甲基-1,2-苯并异*唑-5-基)-1-哌嗪基]乙基]-2-(1-丙炔基)-7H-吡唑-[4,3-e]-[1,2,4]-三唑-[1,5-c]嘧啶-5-胺 7- [2- [4- (6-fluoro-3-methyl-1,2-benzisoxazol * 5-yl) -1-piperazinyl] ethyl] -2- (1-propynyl yl) -7H- pyrazolo - [4,3-e] - [1,2,4] - triazolo - [1,5-c] pyrimidine-5-amine
01/2012
01/31/2012US8106194 Pyrrolopyrimidine and pyrrolotriazine derivatives
01/31/2012US8106189 Process for preparation of triazol-benzodiazepine derivatives
01/31/2012US8106187 Process for the preparation of a macrocycle
01/31/2012US8106186 Transition metal phosphine complex, method for producing same, and anticancer agent containing transition metal phospine complex
01/31/2012US8106052 Luminescence-based methods and probes for measuring cytochrome P450 activity
01/31/2012US8106050 Derivatives of pyrrolo-pyrazines having a kinase inhibitory activity and their biological applications
01/31/2012US8106049 Reverse-turn mimetics and method relating thereto
01/31/2012US8106048 protozoal infestations in humans and animals, by bacteria, viruses or proteinaceous agents; neurological diseases or disorders; ischemia and/or reperfusion injury; 4-(4-Ethoxycarbonyl-4,5-dihydro-thiazol-2-yl)-piperidine-1-carboxylic acid t-butyl ester
01/31/2012US8106041 Combination product comprising an antagonist or inverse agonist of histamine receptor H3 and an antipsychotic and antidepressant agent, and use thereof for the preparation of a medicament that prevents the adverse effects of psychotropic drugs
01/31/2012US8105829 Fluorometric analysis kit
01/31/2012CA2514135C 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
01/31/2012CA2508233C New substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions
01/31/2012CA2463989C Pyrimidine derivatives, pharmaceutical compositions containing these compounds, the use thereof and process for the preparation thereof
01/26/2012WO2012012809A2 APPLICATION OF β-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT
01/26/2012WO2012012764A1 Noribogaine compositions
01/26/2012WO2012012712A2 Tricyclic proteasome activity enhancing compounds
01/26/2012WO2012012117A2 Fusing porphyrins with polycyclic aromatic hydrocarbons and heterocycles for optoelectric applications
01/26/2012WO2012011847A1 Substituted indoles, antiviral active component, method for producing and using same
01/26/2012WO2012011606A1 Process for preparing adenine compounds and intermediates thereof
01/26/2012WO2012010704A1 New aminopyrazoloquinazolines
01/26/2012WO2012010663A1 2,3,5-trisubstituted thiophene compounds and uses thereof
01/26/2012US20120022250 Process for preparing cephalotaxine esters
01/26/2012US20120022053 Oxadiazine Derivatives
01/26/2012US20120022045 Bridged compounds as hiv integrase inhibitors
01/26/2012US20120022043 Pyrazolopyrimidine jak inhibitor compounds and methods
01/26/2012US20120021907 Novel herbicides
01/26/2012US20120021897 Ring compound
01/26/2012US20120020893 Intravascular Imaging Device and Uses Thereof
01/26/2012CA2808432A1 Tricyclic proteasome activity enhancing compounds
01/26/2012CA2806476A1 Substituted indoles, antiviral active component, method for producing and using same
01/26/2012CA2806232A1 Noribogaine compositions
01/26/2012CA2806108A1 2,3,5-trisubstituted thiophene compounds and uses thereof
01/26/2012CA2805427A1 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
01/26/2012CA2803467A1 New aminopyrazoloquinazolines
01/26/2012CA2801353A1 Fusing porphyrins with polycyclic aromatic hydrocarbons and heterocycles for optoelectric applications
01/25/2012EP2410001A1 Inclusion complex, curing agent, cure accelerator, epoxy resin composition, and epoxy resin composition for encapsulation of semiconductor
01/25/2012EP2409978A2 A novel process for the synthesis of pemetrexed disodium salt
01/25/2012EP2408802A1 Cyclic amino acid molecules and methods of preparing the same